During the 66th American Society of Hematology Annual Meeting and Exposition, investigators revealed early-phase 1 data evaluating various BTK degraders that leverage different strategies to overcome ...
New in vitro neutralization data show continued, consistent neutralizing activity of PEMGARDA (pemivibart) against XEC Centers for Disease Control reports XEC and KP.3.1.1 (previously disclosed as sus ...